1. Histones and Their Modifications in Ovarian Cancer – Drivers of Disease and Therapeutic Targets
   Deborah J. Marsh et al, 2014, Frontiers in Oncology CrossRef
2. Small Molecules Simultaneously Inhibiting p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs): Discovery of Novel Multitargeting Antitumor Agents
   Shipeng He et al, 2018, Journal of Medicinal Chemistry CrossRef
3. Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines
   Katharina Stenzel et al, 2017, Journal of Medicinal Chemistry CrossRef
4. Strategy for Traceless Codrug Delivery with Platinum(IV) Prodrug Complexes Using Self-Immolative Linkers
   Violet Eng Yee Lee et al, 2021, Inorganic Chemistry CrossRef